Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 1143220210640040345
Obstetrics & Gynecology Science
2021 Volume.64 No. 4 p.345 ~ p.352
Does the timing of cabergoline administration impact rates of ovarian hyperstimulation syndrome?
Rubenfeld Eryn Sara

Dahan Michael Haim
Abstract
Objective: Does the timing of cabergoline administration impact the rate of mild/moderate ovarian hyperstimulation syndrome in women with a GnRH agonist trigger?

Methods: We conducted a retrospective cohort analysis of 285 in-vitro fertilization patients at risk of OHSS who received a GnRH agonist trigger from 2011 to 2019 at McGill University Health Centre. Group 1 (Trig, n=101) began taking cabergoline 0.5 mg orally for 7 days at the time of GnRH agonist trigger, while Group 2 (Retriev, n=184) started taking cabergoline on the day of oocyte retrieval. The rates of OHSS were then compared between the groups using analysis of variance and chi-square analysis, where appropriate.

Results: The baseline demographic characteristics of the two groups were similar. Trig appeared to be at a slightly higher risk of OHSS based on a significantly higher antral follicle count (20.2¡¾4.2 vs. 19.0¡¾4.3; P=0.02), higher number of stimulated follicles >10 mm at trigger (25.7¡¾7.0 vs. 22.8¡¾8.3, P=0.003), and higher peak serum E2 level (17,325¡¾2,542 vs. 14,822¡¾3,098; P=0.0001). The Trig group had lower rates of mild and moderate OHSS (24% vs. 36%; P=0.045). Neither group had any patients who developed severe OHSS. Trig had fewer patients presenting with pelvic free fluid (13% vs. 23%; P=0.03), lower hematocrit (37.8¡¾4.8% vs. 40.5¡¾4.2%; P=0.0001), higher albumin concentrations (30.4¡¾2.7 vs. 29.5¡¾2.0; P=0.01), and lower potassium concentrations (3.9¡¾0.5 vs. 4.2¡¾0.7; P=0.0002).

Conclusion: Cabergoline at the time of trigger as compared to the time of collection should be investigated to assess its role in reducing the rates of mild/moderate OHSS.
KEYWORD
Cabergoline, In-vitro fertilization, Gonadotropin-releasing hormone, Ovarian hyperstimulation syndrome
FullTexts / Linksout information
Listed journal information
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø